Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Funding working capital requirements
Augmenting working capital resources to support expanding business operations and inventory requirements.
General corporate purposes
Funding strategic growth initiatives, capital expenditure, and operational expenses.
No documents added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Heranba Industries Limited is a leading crop protection chemical manufacturer based in Gujarat, India, incorporated in March 1992. The company specializes in the end-to-end synthesis, manufacture, and distribution of synthetic pyrethroids, agrochemical technicals, intermediates, and formulations used across agriculture and public health applications. Operating across three primary business segments (technicals, formulations, and public health products), Heranba manufactures a diverse product lineup including insecticides, herbicides, and fungicides. The company maintains three state-of-the-art manufacturing facilities in Vapi, Gujarat, and exports products to over 60 countries across Latin America, Asia-Pacific, the Middle East, and Africa, supported by an extensive domestic distribution network of over 8,600 dealers. Backed by fully integrated backward-and-forward manufacturing capabilities, robust in-house R&D, and extensive product registrations globally, Heranba maintains strong market share in synthetic pyrethroid technicals in India. The company continues to drive growth through capacity expansion, new product registrations, and deepening penetration in high-margin export markets while keeping debt levels prudent.
Heranba Industries Limited raised Rs 187.51 crore from 18 anchor investors on February 22, 2021, allocating 2,990,520 equity shares at the cap price of Rs 627 per share. Key participants included Government Pension Fund Global, HDFC Mutual Fund, IDFC Mutual Fund, Cohesion Benefit Fund, and Elara India Opportunities Fund.
Source: RHP • Analysis provided for informational purposes
Last Updated: 28 July 2026, 7:24 AM
Leading Market Position in Synthetic Pyrethroids
Holds a significant share of the domestic synthetic pyrethroid technicals market with integrated manufacturing capabilities.
Diversified Product Portfolio and Global Reach
Operates across technicals, branded formulations, and public health chemicals, exporting to over 60 countries.
Wide Domestic Distribution Network
Supported by an expansive network of thousands of dealers and distributors across major agricultural states in India.
Strong Financial Track Record
Demonstrates consistent revenue growth, expanding profit margins, and disciplined capital structure.
Regulatory and Environmental Compliance Risks
Operates chemical synthesis plants subject to stringent environmental regulations, safety standards, and potential government policy changes.
Raw Material Price Volatility
Dependent on imported key starting materials and chemical intermediates, exposing margins to price fluctuations and supply chain disruptions.
Climatic and Seasonal Dependence
Subject to seasonal monsoon variations and agricultural cycles that directly impact domestic demand for agrochemicals.
Heranba Industries Limited
2nd Floor, A Wing, Fortune Avirahi, Jain Derasar Road, Borivali (West), Mumbai - 400092, Maharashtra, India
View on Maps →No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.